United States Ninth Circuit
In Re Atossa Genetics Inc Securities Litigation, 14-35933
Following the district court's dismissal of an amended securities fraud class action alleging that a company and CEO made materially false or misleading public statements about their breast cancer screening products the panel made a series of holdings affirming, reversing, and vacating parts of the prior decision and analyzing the sufficiency of the various pleadings.
Appellate Information
- Published 2017/08/18
Judges
- GOULD
Court
- United States Ninth Circuit